FULGENT GENETIC Revenue, Profits - FLGT Quarterly Income Statement

Add to My Stocks
$4.56 $0.11 (2.47%) FLGT stock closing price Jun 18, 2018 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking FULGENT GENETIC stock price alone is not sufficient. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has grown from 4.28M to 4.65M and how operating and non operating activities have impacted the FLGT stock. Revenue for year 2018 Q1 is $4.65M and has increased from $4.28M quarter on quarter as is evident when you compare the latest figures in the latest FULGENT GENETIC profit and loss statement with those of the prior corresponding period. Also see FULGENT GENETIC assets and FULGENT GENETIC free cash flow for a complete valuation of FLGT stock.

View and download details of revenue and profits for FULGENT GENETIC for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
FULGENT GENETIC Revenues or Net Sales
4.65M4.28M4.5M4.64M5.31M5.85M5.01M-3.44M
Cost Of Goods Sold (COGS)2.77M2.57M2.26M1.87M1.85M3.28M2.14M-1.3M
FULGENT GENETIC Gross Profit
1.88M1.74M2.23M2.76M3.44M6.56M2.86M-2.13M
Research & Development Expense1.45M1.33M1.12M--1.47M1.52M--
Selling General & Admin Expense2.61M2.49M2.58M1.99M2.37M2.84M2.04M-2.19M
Income Before Depreciation Depletion Amortization-2.19M-2.06M-1.48M-0.15M-2.21M-0.69M--0.61M
Depreciation Depletion Amortization---------
Non Operating Income------5.4M---
Interest Expense---------
FULGENT GENETIC Pretax Income
-2.09M-1.97M-1.33M-0.03M--3.17M-0.69M--0.6M
Provision for Income Taxes-0.43M-0.59M-0.41M-0.11M-----
MinorityInterest---------
Investment Gains Losses-0.24M-0.25M-0.17M-0.1M-----
Other Income---------
Income Before Extraordinaries & Disc Operations-1.91M-1.78M-1.09M-0.03M---1.11M--0.6M
Extraordinary Items & Discontinued Operations---------
FULGENT GENETIC Profit/ Loss (Net Income)
-1.91M-1.78M-1.09M-0.03M---1.11M--0.54M
Average Shares used to compute Diluted EPS17.86M17.81M17.75M17.71M18.18M17.8M12.85M--
Average Shares used to compute Basic EPS17.86M17.81M17.75M17.71M17.68M17.45M12.85M--
Income Before Nonrecurring Items-1.58M-1.53M-0.99M-0.05M---1.11M--
Income from Nonrecurring Items-0.33M-0.25M-0.1M--0.11M----
FULGENT GENETIC Earnings Per Share Basic Net
-0.11-0.10-0.060.000.010.05-0.44--
FULGENT GENETIC Earnings Per Share Diluted Net
-0.11-0.10-0.060.000.010.05-0.44--
EPS Diluted Before Nonrecurring Items-0.08-0.09-0.050.000.020.05-0.44--
Preferred Dividends Acc Pd---------
Dividends Common0.000.00-------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

It is very helpful to read a report on FULGENT GENETIC stock analysis. An investor must check the following items in an income statement:

  • Topline: A growing topline, as seen from the FULGENT GENETIC revenue chart, as is the case with FULGENT GENETIC indicates a growing business. One needs to compare the QoQ topline or sales growth of FLGT stock with its peers like MOTS stock and MGTI stock to see if the growth compares well with what can be expected from a company in that industry.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. FLGT stock had a poor bottom line growth.

The income statement is also called the profit and loss statement. Apart from the FLGT income statement, one can check the FULGENT GENETIC historical stock prices to check how the price has moved with time.

FULGENT GENETIC Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
4.51
Dividend Yield
0%